ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Why GLP-1 weight loss drugs are catching investor attention"
Episode Synopsis
This week Stanford Brown CEO Vincent O'Neill meets once again with CIO Nick Ryder to discuss: The RBA's widely anticipated rate hike and where to from here? Driving factors behind Australia's higher-than-expected inflation numbers Whether geopolitical risks impact portfolio positioning? The potential for GLP-1 "wonder drugs" to impact different companies such as Resmed and CSL Music provided by: Autumn Trumpet Background Corporate by LesFM | https://lesfm.net/ Music promoted by https://www.chosic.com/free-music/all/ Creative Commons CC BY 3.0 https://creativecommons.org/licenses/by/3.0/
More episodes of the podcast SB Talks
SB Talks: Data Surprises & Data Centres
02/12/2025
In God we trust